Literature DB >> 19540321

Assessment factors for extrapolation from short-time to chronic exposure--are the REACH guidelines adequate?

Katarzyna Malkiewicz1, Sven Ove Hansson, Christina Rudén.   

Abstract

Due to the relative scarcity of long-term toxicity data, assessment factors for extrapolation from relatively short to chronic exposures have an important role in the risk assessment of chemicals. A recent REACH guidance document includes recommended default assessment factors that cover subacute-subchronic, subchronic-chronic, and subacute-chronic extrapolations. The recommended assessment factors are smaller than in most previous proposals, since they are calibrated to achieve central estimates (50th percentile of the target distribution) rather than a higher percentile such as the 95th, as has been more common. These assessment factors are nevertheless presented as representing a "widely agreed level of conservatism", a statement that may lead to misunderstandings of what is achieved by using them in a risk assessment. Assessment factors have been based on evidence from animal studies with different designs, in particular with focus on different endpoints. Our re-analysis of experimental data shows that using mortality as an endpoint leads to smaller assessment factors than if the factors are derived from corresponding ratios for non-lethal toxicity.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19540321     DOI: 10.1016/j.toxlet.2009.06.858

Source DB:  PubMed          Journal:  Toxicol Lett        ISSN: 0378-4274            Impact factor:   4.372


  2 in total

1.  Issues to consider in the derivation of water quality benchmarks for the protection of aquatic life.

Authors:  Uwe Schneider
Journal:  Environ Sci Pollut Res Int       Date:  2014-01       Impact factor: 4.223

2.  Focus on Chronic Exposure for Deriving Drinking Water Guidance Underestimates Potential Risk to Infants.

Authors:  Helen Goeden
Journal:  Int J Environ Res Public Health       Date:  2018-03-14       Impact factor: 3.390

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.